• Balchem highlighted new clinical research published in Nutrients showing its VitaCholine choline ingredient influenced brain activation tied to working memory in postmenopausal women.
• Results have already been presented via publication, marking first fMRI-based study to report choline-related changes in brain network efficiency in this population.
• Trial design used randomized cross-over dosing of 1,650 mg choline versus placebo in 20 healthy women aged 50-65.
• Study reported rapid shifts in functional connectivity consistent with more efficient working-memory network function, supporting positioning of VitaCholine in women’s healthy-aging formulations.
• Balchem indicated follow-on research is underway to build on preliminary findings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Balchem Corporation published the original content used to generate this news brief on April 16, 2026, and is solely responsible for the information contained therein.